Ettore Ferrari Júnior

Dr. Ettore Ferrari Júnior

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2017 in Forensic Toxicology
Verified
Journal Article
Open access
PDF file
Luciano ArantesLuciano Arantes
Luciano Arantes
EJEttore Ferrari Júnior
Ettore Ferrari Júnior
LSLuciano Figueiredo de Souza
Luciano Figueiredo de Souza
ACAndriele Costa Cardoso
Andriele Costa Cardoso
TAThaynara Lino Fernandes Alcântara
Thaynara Lino Fernandes Alcântara
AAAna Flávia B. Andrade
Ana Flávia B. Andrade
A new potent serotonin 5-HT2A receptor agonist was identified in blotter papers by several state level forensic laboratories in Brazil. The 25I-NBOH is a labile molecule, which fragments into 2C-I when analyzed by routine seized material screening gas chromatography (GC) methods. GC–mass spectrometry (MS), liquid chromatography–quadrupole time-of-flight-MS, and Fourier transform infrared and nuclear magnetic resonance analyses were performed to complete molecular characterization. Individual doses range from 300 to 1000 μg. Despite its being a potent 5-HT2A receptor agonist, 25I-NBOH is neither registered in the United Nations Office on Drugs and Crime (UNODC) nor classified as a scheduled substance in most countries. Sweden and Brazil seem to be the only countries to control 25I-NBOH. To our knowledge, this is the first scientific report dealing with identification of 25I-NBOH in actual seizures.


24 March 2017 in Forensic Toxicology
Verified
Journal Article
Closed access
PDF file
JNJosé Coelho Neto
José Coelho Neto
AAAna Flávia B. Andrade
Ana Flávia B. Andrade
RLRogério Araújo Lordeiro
Rogério Araújo Lordeiro
YMYuri Machado
Yuri Machado
MEMathieu Elie
Mathieu Elie
Luciano ArantesLuciano Arantes
Luciano Arantes

21 March 2022 in Forensic Science International
Verified
Journal Article
Closed access
DSDiego Mendes de Souza
Diego Mendes de Souza
PMPedro Judah de Moura Messias
Pedro Judah de Moura Messias
ISIsabella da Silva Santos
Isabella da Silva Santos
EREduardo Dias Ramalho
Eduardo Dias Ramalho
EJEttore Ferrari Júnior
Ettore Ferrari Júnior
PMPedro Augusto de Oliveira Morais
Pedro Augusto de Oliveira Morais

8 April 2024 in International Journal of Mental Health and Addiction
Verified
Journal Article
Open access
PDF file
AGAndrea Donatti Gallassi
Andrea Donatti Gallassi
AOAndré Wagner Carvalho de Oliveira
André Wagner Carvalho de Oliveira
LRLarissa Alencar Rodrigues
Larissa Alencar Rodrigues
Eduardo Yoshio NakanoEduardo Yoshio Nakano
Eduardo Yoshio Nakano
PRPedro A. S. Ruas
Pedro A. S. Ruas
RMRenato Malcher-Lopes
Renato Malcher-Lopes
Cannabidiol (CBD) has been studied for substance use disorders treatment due to its anxiolytic effects, for sleep, appetite, reduction of craving, and maintenance of abstinence. The study aims to assess CBD’s feasibility, safety/tolerability, and preliminary efficacy compared to pharmacological treatment as usual for reducing crack use in people with crack use disorder (CUD) and investigate other parameters: adverse events, physical health symptoms, and craving. A double-blind, randomized clinical trial (RCT) with two treatment arms (CBD and control group) was conducted. Ninety participants were randomized and 73 were allocated: 37 control group and 36 CBD group for a 10-week treatment, comparing CBD (600 mg) with three drugs (fluoxetine, valproic acid, and clonazepam). The per-protocol analysis of participants who did not deviate from the study protocol compared the control and CBD treatment groups. Thirty-four completed at least half of the study and 25 finished. Participants attended weekly meetings for the study procedures (e.g., to receive the medication and provide urine for toxicological tests). Inter-group differences were performed with the Mann–Whitney test, the Wilcoxon test for differences intra-group, and Pearson’s Chi-square test or Fisher’s exact test to compare inter-group demographic data. The significance level was 5%. A “veracity index” (VI) was created as counterevidence (questionnaire data vs. the toxicological test result). Medications were considered safe/tolerable. The CBD group presented significantly fewer adverse events compared to the control group [e.g., dizziness (p = 0.001), memory impairment (p = 0.043)], which performed better in the reduction of clinical and psychiatric complaints (p = 0.008). In the intra-group analyses, the CBD group performed better in more parameters than the control group [e.g., reducing crack use (p = 0.016; T0 to T1)]. Data questionnaires were reliable regarding the use/non-use of crack (VI = 0.787). CBD is a safe/tolerable product. The CBD group manifested fewer adverse events than the control group, which had better clinical and psychiatric complaints results. There are some advantages for the CBD group in the intra-group analysis. Drug use self-report methodologies can be reliable. Trial registration details: This study is registered with Universal Trial Number (UTN) code: U1111-1234-0806. Available at https://ensaiosclinicos.gov.br/rg/RBR-4stgs8 (Effect of cannabidiol in the treatment of crack dependents)

2 March 2024 in Forensic Sciences
Verified
Journal Article
Open access
PDF file
Rodrigo S. CorreaRodrigo S. Correa
Rodrigo S. Correa
RRRenata Esteves Ribeiro
Renata Esteves Ribeiro
MBMarina Pereira Borges
Marina Pereira Borges
EJEttore Ferrari Júnior
Ettore Ferrari Júnior
JGJuliano de Andrade Gomes
Juliano de Andrade Gomes
Forensic soil analysis is crucial in criminal investigations, necessitating robust analytical methodologies for an accurate discrimination of soil types and origins. This study explored the discrimination efficiency of thermogravimetric and differential scanning calorimetric analyses of Inceptisol, reddish Oxisol, and yellowish Oxisol soils from Brazil’s Cerrado region. Ninety air-dried soil samples collected at various locations underwent thermal analysis, focusing on mass loss of gibbsite, goethite, and kaolinite at specific temperatures. The log-transformed data were submitted to principal component analysis, nonmetric multidimensional scaling, and cluster analysis. The thermogravimetry emerged as a highly discriminatory tool, effectively delineating between soil types, and even detecting spatial variations. In contrast, the differential scanning calorimetry exhibited limited discriminatory power. The findings underscore the thermogravimetric potential as a valuable technique in soil forensics, providing critical insights into composition and spatial variations essential for criminal investigations. This study highlights the need for further research to explore synergies with complementary techniques, aiming to enhance forensic discrimination across diverse soil types and geographic contexts. The objective representation of results in this abstract emphasizes the significance of thermogravimetry in advancing forensic analysis of soil vestiges.